Trial NCT04373460
Publication Sullivan D, N Engl J Med (2022) (published paper)
Primary outcome on the report: Covid-19–related hospitalization within 28 days after transfusion, assessed as the cumulative incidence in the convalescent- plasma group as compared with the control-plasma group. Although death before hospitalization was part of the protocol-specified primary outcome, it did not occur in the trial. Hence, the primary outcome is equivalent to Covid-19–related hospitalization.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.